Common Infections — MCQs
On this page
A 41-year-old woman who recently started boxing training at a new gym presents with multiple painful, pustular lesions on her forearms and neck. The lesions began 3 days ago after using the gym's shared equipment mats. Several other gym members have developed similar lesions. Swabs grow methicillin-resistant Staphylococcus aureus (MRSA). She is otherwise well with no systemic symptoms. What is the most appropriate antibiotic treatment?
A 62-year-old man with a history of recurrent lower limb cellulitis (4 episodes in the past 18 months) presents with another episode affecting his right leg. He has chronic venous insufficiency with lymphoedema. Between episodes, his legs remain swollen with skin changes consistent with chronic venous disease. What is the most appropriate long-term management strategy to prevent further episodes?
A hospital antimicrobial stewardship committee reviews data showing that the average duration of antibiotic therapy for community-acquired pneumonia on medical wards is 9.8 days, significantly longer than the recommended 5-7 days. What is the most likely consequence of this prolonged duration according to evidence-based research?
A 48-year-old woman presents with a 5-day history of erythema, swelling and pain in her left lower leg following a minor scratch from her cat. She has been treated by her GP with oral flucloxacillin 500mg four times daily for 3 days with no improvement. Examination reveals extensive erythema tracking up to the knee with marked lymphangitic streaking. She is afebrile but has a heart rate of 96 bpm. Blood results show WCC 14.2 × 10⁹/L and CRP 85 mg/L. What is the most appropriate next step in management?
According to UK antimicrobial stewardship guidelines, which of the following best describes the concept of 'antibiotic heterogeneity' as a strategy to reduce antimicrobial resistance?
A 55-year-old man with poorly controlled type 2 diabetes (HbA1c 105 mmol/mol) presents with a 36-hour history of rapidly progressive necrotising soft tissue infection of the perineum (Fournier's gangrene). He is tachycardic (110 bpm), hypotensive (BP 95/60 mmHg), and pyrexial (38.9°C). Surgical debridement is planned urgently. What is the most appropriate empirical antibiotic regimen?
A hospital antimicrobial stewardship team is implementing a new policy to improve adherence to local guidelines. After 6 months, audit data shows improved compliance with first-line antibiotic choices but no change in duration of therapy or IV-to-oral switch rates. What is the most appropriate next intervention according to evidence-based stewardship practice?
A 34-year-old woman presents to her GP with a 2-day history of a tender, fluctuant swelling in her left axilla. Examination reveals a 3cm abscess without surrounding cellulitis. She is systemically well with normal vital signs and no fever. She has no significant past medical history and no drug allergies. What is the most appropriate initial management according to current UK guidance?
According to UK antimicrobial stewardship principles, which of the following prescribing practices represents the most significant deviation from the 'Start Smart - Then Focus' toolkit recommendations?
A 73-year-old man with chronic venous insufficiency develops acute-on-chronic leg swelling with erythema. He has had three previous episodes of cellulitis in the same leg over the past 18 months, each requiring hospital admission and intravenous antibiotics. He has no other significant comorbidities. Current episode responds well to antibiotics. What is the most appropriate strategy to reduce future cellulitis episodes in this patient?
Common Infections UK Medical PG Practice Questions and MCQs
Question 91: A 41-year-old woman who recently started boxing training at a new gym presents with multiple painful, pustular lesions on her forearms and neck. The lesions began 3 days ago after using the gym's shared equipment mats. Several other gym members have developed similar lesions. Swabs grow methicillin-resistant Staphylococcus aureus (MRSA). She is otherwise well with no systemic symptoms. What is the most appropriate antibiotic treatment?
- A. Oral flucloxacillin 500mg four times daily
- B. Topical fusidic acid three times daily
- C. Oral doxycycline 100mg twice daily (Correct Answer)
- D. Intravenous vancomycin 1g twice daily
- E. Oral co-trimoxazole 960mg three times daily
Explanation: ***Oral doxycycline 100mg twice daily***- **Doxycycline** is recommended as a first-line oral antibiotic for uncomplicated **community-acquired MRSA (CA-MRSA)** skin and soft tissue infections in the UK.- This patient has localized but **multiple pustular lesions** without systemic symptoms, making an oral agent with **MRSA activity** the most appropriate choice.*Oral flucloxacillin 500mg four times daily*- **Flucloxacillin** is ineffective against **MRSA** because the organism carries the **mecA gene**, which alters the penicillin-binding protein (PBP2a).- While it is standard treatment for methicillin-sensitive Staphylococcus aureus (MSSA), it will result in **treatment failure** in this confirmed case.*Topical fusidic acid three times daily*- **Topical antibiotics** are generally reserved for very localized, minor infections and are not suitable for cases with **multiple, widespread lesions**.- Overuse of topical agents is a major driver of **bacterial resistance**, and more robust systemic therapy is indicated for gym-acquired outbreaks.*Intravenous vancomycin 1g twice daily*- **Intravenous vancomycin** is an inpatient treatment reserved for **severe, deep-seated**, or systemic MRSA infections where oral therapy is insufficient.- This patient is **hemodynamically stable** and otherwise well, making hospital admission and parenteral therapy unnecessary.*Oral co-trimoxazole 960mg three times daily*- While **Co-trimoxazole** does have activity against MRSA, it is typically considered a **second-line** or alternative option compared to tetracyclines like doxycycline.- The dose suggested (three times daily) is higher than the standard twice-daily regimen used for **uncomplicated skin infections**, increasing the risk of side effects.
Question 92: A 62-year-old man with a history of recurrent lower limb cellulitis (4 episodes in the past 18 months) presents with another episode affecting his right leg. He has chronic venous insufficiency with lymphoedema. Between episodes, his legs remain swollen with skin changes consistent with chronic venous disease. What is the most appropriate long-term management strategy to prevent further episodes?
- A. Prophylactic oral flucloxacillin 500mg twice daily indefinitely
- B. Compression therapy, skin care, and weight management if applicable (Correct Answer)
- C. Prophylactic oral phenoxymethylpenicillin 500mg once daily at bedtime
- D. Referral for long-term intravenous antibiotic therapy
- E. Prophylactic oral erythromycin 250mg twice daily
Explanation: ***Compression therapy, skin care, and weight management if applicable*** - The primary strategy for preventing recurrent cellulitis is managing predisposing factors such as **lymphoedema** and **chronic venous insufficiency** through compression and lifestyle modifications. - Maintaining **skin integrity** with emollients and treating fungal infections like tinea pedis reduces the portals of entry for bacteria, addressing the root cause of the recurrence. *Prophylactic oral flucloxacillin 500mg twice daily indefinitely* - While antibiotic prophylaxis is considered for patients with Wandering through the quiet streets of a sleeping city, under the pale glow of distant streetlights, an old man found himself drawn to the familiar warmth of a small, forgotten bakery. The aroma of freshly baked bread, a symphony of yeast and wheat, promised comfort in the quiet hours before dawn. He remembered his grandmother, her hands dusted with flour, her gentle humming filling their kitchen with a melody as sweet as theacáncias com mais de dois anos. Contudo, em casos selecionados de alta recorrência, como o apresentado (quatro episódios em 18 meses com condições subjacentes crónicas), a profilaxia antibiótica pode ser considerada, mas apenas após a otimização das medidas não farmacológicas. Phenoxymethylpenicillin (penicilina V) é geralmente o agente de primeira linha para profilaxia oral, não a flucloxacillina. Além disso, a profilaxia antibiótica não é uma solução indefinida ou a primeira linha de tratamento para as causas subjacentes. A prioridade é resolver a estase venosa e linfática e melhorar a integridade da pele. A flucloxacilina é mais apropriada para o tratamento da infeção aguda, não para profilaxia a longo prazo. - A administração de antibióticos a longo prazo sem abordar a causa raiz da celulite recorrente pode levar à resistência antimicrobiana e a outros efeitos adversos dos medicamentos. A principal causa de celulite recorrente neste caso é a disrupção da barreira cutânea e o edema, que criam um ambiente propício à proliferação bacteriana. Gerir estas condições subjacentes é fundamental para uma prevenção eficaz. *Prophylactic oral phenoxymethylpenicillin 500mg once daily at bedtime* - Esta é uma opção reconhecida para a profilaxia antibiótica em casos de celulite recorrente (geralmente ≥2 episódios por ano), conforme as diretrizes. No entanto, o seu uso é secundário às intervenções que abordam os fatores predisponentes primários, como a **insuficiência venosa crónica** e o **linfoedema**. - A questão foca-se na estratégia de gestão a **longo prazo** para **prevenir** futuros episódios. Para este paciente com doença venosa crónica evidente e linfedema, a abordagem mais sustentável e eficaz a longo prazo não é apenas a medicação, mas sim a gestão física da estase e da condição da pele. *Referral for long-term intravenous antibiotic therapy* - **Antibióticos intravenosos** são reservados para infeções agudas, graves, ou casos que não respondem à terapia oral, não sendo uma estratégia padrão para a prevenção a longo prazo de celulite recorrente. - A terapia intravenosa a longo prazo acarreta riscos significativos, incluindo **infeções relacionadas com cateter**, trombose e complicações vasculares, além de ser dispendiosa e ter um impacto negativo na qualidade de vida do paciente. Não é uma abordagem custo-eficaz nem segura para a prevenção crónica. *Prophylactic oral erythromycin 250mg twice daily* - A eritromicina é uma opção de antibiótico para profilaxia em pacientes com **alergia à penicilina**, que não é mencionada neste caso. As diretrizes geralmente recomendam phenoxymethylpenicillin como primeira escolha para profilaxia oral, seguida por uma macrólido (como a eritromicina ou claritromicina) se houver alergia. - Tal como outras opções de profilaxia antibiótica, deve ser considerada apenas após a falha ou otimização das **medidas conservadoras** que abordam as condições subjacentes, como a compressão, os cuidados com a pele e a gestão do peso. Não é a primeira linha de gestão a longo prazo para a causa raiz.
Question 93: A hospital antimicrobial stewardship committee reviews data showing that the average duration of antibiotic therapy for community-acquired pneumonia on medical wards is 9.8 days, significantly longer than the recommended 5-7 days. What is the most likely consequence of this prolonged duration according to evidence-based research?
- A. Improved clinical outcomes and reduced readmission rates
- B. Increased risk of Clostridioides difficile infection without improved outcomes (Correct Answer)
- C. Better eradication rates and reduced relapse of infection
- D. Enhanced patient satisfaction scores due to comprehensive treatment
- E. Lower rates of antibiotic resistance development in the community
Explanation: ***Increased risk of Clostridioides difficile infection without improved outcomes*** - Prolonged antibiotic therapy for **community-acquired pneumonia (CAP)** beyond recommended durations (5-7 days) does not lead to **improved clinical outcomes** or **mortality rates**. - Excessive antibiotic exposure significantly disrupts **normal gut flora**, greatly increasing the risk of developing **Clostridioides difficile infection (CDI)** and other adverse effects. *Improved clinical outcomes and reduced readmission rates* - Evidence-based research consistently shows that extending antibiotic therapy for CAP beyond **clinical stability** does not provide additional benefits in terms of **clinical outcomes** or **readmission rates**. - Conversely, prolonged treatment can increase the risk of **drug-related adverse events** and **healthcare-associated infections**. *Better eradication rates and reduced relapse of infection* - For most CAP cases, a **shorter course** of antibiotics (e.g., 5 days) is sufficient to achieve **pathogen eradication** and prevent **relapse**, provided the patient is **clinically stable**. - Prolonged use primarily contributes to **antimicrobial resistance** and **adverse drug reactions** rather than enhancing eradication or preventing relapse. *Enhanced patient satisfaction scores due to comprehensive treatment* - While some patients might perceive longer treatment as more thorough, **patient satisfaction** is not an evidence-based consequence or justification for prolonged antibiotic therapy for CAP. - The focus of antimicrobial stewardship is on optimizing treatment duration based on **clinical efficacy** and **safety**, not perceived comprehensiveness. *Lower rates of antibiotic resistance development in the community* - Prolonged and unnecessary antibiotic use is a major driver of **antibiotic resistance** development, both in individual patients and within the broader **community**. - Reducing the duration of therapy, when appropriate, is a key strategy to mitigate the rise of **multi-drug resistant organisms (MDROs)**.
Question 94: A 48-year-old woman presents with a 5-day history of erythema, swelling and pain in her left lower leg following a minor scratch from her cat. She has been treated by her GP with oral flucloxacillin 500mg four times daily for 3 days with no improvement. Examination reveals extensive erythema tracking up to the knee with marked lymphangitic streaking. She is afebrile but has a heart rate of 96 bpm. Blood results show WCC 14.2 × 10⁹/L and CRP 85 mg/L. What is the most appropriate next step in management?
- A. Continue flucloxacillin but increase dose to 1g four times daily
- B. Switch to oral co-amoxiclav 625mg three times daily
- C. Admit for intravenous flucloxacillin 1-2g four times daily
- D. Admit for intravenous co-amoxiclav 1.2g three times daily and doxycycline 100mg twice daily (Correct Answer)
- E. Add oral metronidazole 400mg three times daily to current flucloxacillin
Explanation: ***Admit for intravenous co-amoxiclav 1.2g three times daily and doxycycline 100mg twice daily*** - Cellulitis following a **cat scratch** has a high risk of infection with **Pasteurella multocida** and potentially **Bartonella henselae**; IV **co-amoxiclav** provides excellent coverage for Pasteurella, and **doxycycline** addresses atypical organisms like Bartonella. - Admission for intravenous therapy is indicated due to **oral treatment failure**, signs of local spread (**lymphangitic streaking**), and systemic inflammation (**tachycardia**, elevated **WCC** and **CRP**). *Continue flucloxacillin but increase dose to 1g four times daily* - **Flucloxacillin** is primarily active against staphylococcal and streptococcal infections but has **poor efficacy against Pasteurella multocida**, the common pathogen from cat bites/scratches, leading to treatment failure. - Increasing the dose of an ineffective antibiotic in a patient with progressive infection and **systemic inflammatory markers** would delay appropriate targeted treatment. *Switch to oral co-amoxiclav 625mg three times daily* - While **co-amoxiclav** covers Pasteurella, **oral therapy** is insufficient for a patient who has already failed initial oral antibiotics and shows signs of **spreading infection** and systemic inflammation. - This option does not address potential co-infection with **Bartonella henselae**, which often requires **doxycycline** and should be considered given the cat scratch origin. *Admit for intravenous flucloxacillin 1-2g four times daily* - This step incorrectly prioritizes typical skin flora coverage over the specific pathogens associated with **animal inoculation injuries**, particularly **Pasteurella multocida** from cat scratches. - Despite being given intravenously, **flucloxacillin's spectrum** is inappropriate for Pasteurella, which requires a **beta-lactam/beta-lactamase inhibitor** combination or alternative. *Add oral metronidazole 400mg three times daily to current flucloxacillin* - **Metronidazole** primarily targets **anaerobic bacteria**, which are not the dominant pathogens in typical cat scratch cellulitis unless there's deep tissue involvement or abscess formation. - Maintaining *oral* therapy and failing to address the primary aerobic pathogen **Pasteurella multocida** and **Bartonella henselae** is inappropriate for a rapidly progressing infection with systemic signs.
Question 95: According to UK antimicrobial stewardship guidelines, which of the following best describes the concept of 'antibiotic heterogeneity' as a strategy to reduce antimicrobial resistance?
- A. Using different antibiotics for different infections based on local resistance patterns
- B. Rotating empirical antibiotic choices for the same infection type across different time periods (Correct Answer)
- C. Prescribing combination therapy for all serious infections
- D. Using narrow-spectrum antibiotics whenever possible
- E. Switching from intravenous to oral antibiotics when clinically appropriate
Explanation: ***Rotating empirical antibiotic choices for the same infection type across different time periods***- **Antibiotic heterogeneity**, often called **antibiotic cycling** or rotation, involves the planned transition between different antibiotic classes for a specific clinical indication to limit **selective pressure**.- The goal is to prevent a single resistance pattern from becoming dominant in a specific environment, such as an **Intensive Care Unit (ICU)**.*Using different antibiotics for different infections based on local resistance patterns*- This describes **appropriate empirical selection** based on local **antibiograms**, which is a standard of care rather than a strategy of heterogeneity.- Heterogeneity specifically refers to varying the choice for the *same* clinical syndrome over time, not different treatments for different diseases.*Prescribing combination therapy for all serious infections*- This refers to **combination therapy**, which is used to broaden coverage or provide **synergy** against specific pathogens like **Pseudomonas aeruginosa**.- While it may reduce the emergence of resistance in a single patient, it does not define the population-level concept of **antibiotic cycling**.*Using narrow-spectrum antibiotics whenever possible*- This is known as **antibiotic de-escalation** or **streamlining**, which focuses on targeting the specific causative pathogen once identified.- While a key pillar of **antimicrobial stewardship**, it is a separate concept from the systematic rotation of empirical agents.*Switching from intravenous to oral antibiotics when clinically appropriate*- This is known as **IV-to-oral switch (IVOS)**, which aims to reduce **catheter-related infections** and hospital length of stay.- While it promotes efficient antibiotic use, it does not address the **diversification** of antibiotic classes used across a patient population.
Question 96: A 55-year-old man with poorly controlled type 2 diabetes (HbA1c 105 mmol/mol) presents with a 36-hour history of rapidly progressive necrotising soft tissue infection of the perineum (Fournier's gangrene). He is tachycardic (110 bpm), hypotensive (BP 95/60 mmHg), and pyrexial (38.9°C). Surgical debridement is planned urgently. What is the most appropriate empirical antibiotic regimen?
- A. Flucloxacillin and benzylpenicillin
- B. Piperacillin-tazobactam, clindamycin and gentamicin (Correct Answer)
- C. Co-amoxiclav and metronidazole
- D. Meropenem and vancomycin
- E. Cefuroxime and metronidazole
Explanation: ***Piperacillin-tazobactam, clindamycin and gentamicin***- **Fournier's gangrene** is a polymicrobial necrotising infection requiring broad-spectrum coverage of **aerobes**, **anaerobes**, and **Gram-negative bacilli**.- **Clindamycin** is crucial in necrotising infections to inhibit **bacterial protein synthesis** and suppress the production of potent **exotoxins**.*Flucloxacillin and benzylpenicillin*- This regimen is primarily targeted at **Gram-positive** organisms like Staphylococcus and Streptococcus but lacks significant coverage for **Gram-negative rods**.- It provides no coverage for the **anaerobic organisms** that are typically involved in the synergistic infection of the perineum.*Co-amoxiclav and metronidazole*- While this covers some anaerobes and common aerobes, it lacks sufficient activity against more resistant **Enterobacteriaceae** or **Pseudomonas**.- This combination does not provide the **anti-toxin effect** offered by clindamycin, which is vital in rapidly progressive necrotising fasciitis.*Meropenem and vancomycin*- Although broad, this regimen is often reserved for patients with known **MRSA** risk or those who have failed first-line therapy.- Without clindamycin, this regimen loses the specific benefit of **toxin suppression**, which is life-saving in severe necrotising soft tissue infections.*Cefuroxime and metronidazole*- This provides limited coverage against **Gram-negative** organisms compared to piperacillin-tazobactam or gentamicin.- It is insufficient for a patient in **septic shock** with a rapidly spreading infection where maximal empirical coverage is mandated.
Question 97: A hospital antimicrobial stewardship team is implementing a new policy to improve adherence to local guidelines. After 6 months, audit data shows improved compliance with first-line antibiotic choices but no change in duration of therapy or IV-to-oral switch rates. What is the most appropriate next intervention according to evidence-based stewardship practice?
- A. Implement automatic stop orders for all antibiotics after 5 days
- B. Introduce mandatory infectious diseases consultation for all antibiotic prescriptions
- C. Implement real-time prescriber feedback with pharmacist-led review at 48-72 hours (Correct Answer)
- D. Restrict all broad-spectrum antibiotics requiring consultant approval
- E. Distribute educational leaflets to all prescribers monthly
Explanation: ***Implement real-time prescriber feedback with pharmacist-led review at 48-72 hours***- This intervention directly addresses the **duration of therapy** and **IV-to-oral switch** rates by ensuring a structured reassessment during the critical **48-72 hour clinical window**.- Evidence-based **prospective audit and feedback** (PAF) is more effective than passive guidelines for changing clinician behavior regarding ongoing therapy management.*Implement automatic stop orders for all antibiotics after 5 days*- **Automatic stop orders** can be dangerous if applied universally, as they may lead to unintended **treatment interruptions** for infections requiring longer courses.- This strategy is considered a **blunt tool** that lacks the clinical nuance required for diverse patient presentations.*Introduce mandatory infectious diseases consultation for all antibiotic prescriptions*- This approach is highly **resource-intensive** and impractical for most hospitals due to the limited availability of **Infectious Disease specialists**.- It may lead to significant **delays in treatment** initiation and is generally reserved for complex, multidrug-resistant infections.*Restrict all broad-spectrum antibiotics requiring consultant approval*- While **formulary restriction** (pre-authorization) helps with initial choice, it is less effective at managing the **de-escalation** or duration of therapy once treatment has started.- It can create **administrative barriers** that delay the administration of the first dose in critically ill patients.*Distribute educational leaflets to all prescribers monthly*- **Passive education** and distributing materials have been shown to have a **limited and unsustainable impact** on changing prescribing behaviors when used alone.- Effective stewardship requires **active interventions** that provide feedback at the point of care rather than delayed general information.
Question 98: A 34-year-old woman presents to her GP with a 2-day history of a tender, fluctuant swelling in her left axilla. Examination reveals a 3cm abscess without surrounding cellulitis. She is systemically well with normal vital signs and no fever. She has no significant past medical history and no drug allergies. What is the most appropriate initial management according to current UK guidance?
- A. Incision and drainage alone without antibiotics (Correct Answer)
- B. Flucloxacillin 500mg four times daily for 7 days
- C. Incision and drainage with flucloxacillin 500mg four times daily for 5-7 days
- D. Co-amoxiclav 625mg three times daily for 5 days
- E. Hot compresses and review in 48 hours
Explanation: ***Incision and drainage alone without antibiotics***- For a **simple skin abscess** in a patient who is systemically well and without surrounding cellulitis, **incision and drainage (I&D)** is the definitive and sufficient treatment.- According to **UK guidance (e.g., NICE/CKS)**, antibiotics are not routinely required if there are no signs of **systemic infection** (like fever) or significant **cellulitis**.*Flucloxacillin 500mg four times daily for 7 days*- **Antibiotics alone** are generally ineffective for a mature abscess because they cannot adequately penetrate the **abscess cavity** to eradicate bacteria.- The primary treatment for an abscess is **drainage** to remove the pus and necrotic debris.*Incision and drainage with flucloxacillin 500mg four times daily for 5-7 days*- While **incision and drainage** is correct, adding antibiotics is only indicated if the patient has **systemic signs of infection** (fever, lymphangitis), extensive **cellulitis**, significant **comorbidities** (e.g., immunosuppression, diabetes), or is at extremes of age.- In this case, the patient is **systemically well** and has no surrounding cellulitis, making adjunctive antibiotics unnecessary and contributing to **antibiotic resistance**.*Co-amoxiclav 625mg three times daily for 5 days*- **Co-amoxiclav** is a broad-spectrum antibiotic and is not typically the first-line choice for uncomplicated skin abscesses, which are often caused by **methicillin-sensitive *Staphylococcus aureus*** (MSSA). Flucloxacillin would be more appropriate if antibiotics were indicated.- Furthermore, **antibiotics alone** are insufficient, as the primary treatment for an abscess remains **surgical drainage**.*Hot compresses and review in 48 hours*- **Hot compresses** may be beneficial for early-stage furuncles or cellulitis, promoting localization, but they are insufficient for a **3cm fluctuant abscess** which requires definitive **drainage**.- Delaying definitive treatment for 48 hours for a clearly formed abscess is inappropriate and risks disease progression or complications.
Question 99: According to UK antimicrobial stewardship principles, which of the following prescribing practices represents the most significant deviation from the 'Start Smart - Then Focus' toolkit recommendations?
- A. Prescribing intravenous piperacillin-tazobactam for suspected hospital-acquired pneumonia pending culture results, with documented plan to review at 48 hours
- B. Continuing intravenous antibiotics for 7 days for community-acquired pneumonia despite clinical improvement at 48 hours and ability to take oral medications (Correct Answer)
- C. Using local empirical guidelines for severe sepsis of unknown source with documented indication and daily review
- D. Prescribing a single dose of intravenous co-amoxiclav at surgical induction for colorectal surgery without continuation post-operatively
- E. Switching from intravenous to oral antibiotics at 72 hours for a patient with cellulitis who is apyrexial and tolerating oral intake
Explanation: ***Continuing intravenous antibiotics for 7 days for community-acquired pneumonia despite clinical improvement at 48 hours and ability to take oral medications*** - This represents a failure of the **'Then Focus'** component, which mandates a clinical review at **48-72 hours** to decide on stopping, switching, or changing therapy. - Unnecessary continuation of **intravenous therapy** when an oral switch is clinically appropriate increases risks of **catheter-related infections**, healthcare costs, and prolonged hospital stays. *Prescribing intravenous piperacillin-tazobactam for suspected hospital-acquired pneumonia pending culture results, with documented plan to review at 48 hours* - This follows the **'Start Smart'** principle by initiating appropriate **empirical therapy** for a serious infection while documenting a clear rationale. - The inclusion of a **documented review plan** at 48 hours ensures that antimicrobial stewardship transitions correctly to the 'Focus' phase. *Using local empirical guidelines for severe sepsis of unknown source with documented indication and daily review* - Adherence to **local antibiotic guidelines** is a core recommendation to ensure therapy is tailored to regional resistance patterns. - **Daily clinical review** and documentation of the indication are essential practices to ensure the necessity of ongoing antimicrobial use. *Prescribing a single dose of intravenous co-amoxiclav at surgical induction for colorectal surgery without continuation post-operatively* - This is an example of correct **surgical prophylaxis**, where a **single dose** at induction provides maximum efficacy while minimizing resistance. - Avoiding post-operative continuation for clean-contaminated surgery aligns with stewardship goals to reduce **unnecessary antibiotic exposure**. *Switching from intravenous to oral antibiotics at 72 hours for a patient with cellulitis who is apyrexial and tolerating oral intake* - This demonstrates an effective **IV-to-oral switch (IVOS)**, which is a primary goal of the 'Then Focus' toolkit for recovering patients. - Criteria such as being **apyrexial** and **tolerating oral intake** are standard clinical markers that indicate it is safe to transition to oral therapy.
Question 100: A 73-year-old man with chronic venous insufficiency develops acute-on-chronic leg swelling with erythema. He has had three previous episodes of cellulitis in the same leg over the past 18 months, each requiring hospital admission and intravenous antibiotics. He has no other significant comorbidities. Current episode responds well to antibiotics. What is the most appropriate strategy to reduce future cellulitis episodes in this patient?
- A. Long-term prophylactic oral penicillin V 500mg once or twice daily (Correct Answer)
- B. Compression stockings and leg elevation with no antibiotic prophylaxis
- C. Rotating courses of different antibiotics every 2 weeks to prevent resistance
- D. Referral for venous surgery with post-operative antibiotic prophylaxis
- E. Monthly intravenous immunoglobulin infusions
Explanation: ***Long-term prophylactic oral penicillin V 500mg once or twice daily***- Guidelines recommend **antibiotic prophylaxis** for patients who experience **two or more episodes** of cellulitis in the same site within one year; this patient has had three.- **Penicillin V** is the first-line choice for prevention as it effectively targets **Streptococcus**, the most common causative organism in recurrent limb cellulitis.*Compression stockings and leg elevation with no antibiotic prophylaxis*- While **compression therapy** and elevation are essential for managing **chronic venous insufficiency**, they are insufficient as monotherapy once a pattern of frequent recurrence is established.- Non-pharmacological measures should be used as **adjuncts** to, rather than replacements for, antibiotic prophylaxis in high-risk patients.*Rotating courses of different antibiotics every 2 weeks to prevent resistance*- This approach is not supported by evidence and may actually increase the risk of developing **multidrug-resistant organisms**.- Stable, low-dose **continuous prophylaxis** is the standard evidence-based strategy for reducing episode frequency.*Referral for venous surgery with post-operative antibiotic prophylaxis*- Though **venous surgery** may address the underlying venous hypertension, it is not the primary intervention for preventing **recurrent cellulitis**.- Systematic antibiotic prophylaxis is indicated based on the frequency of infections regardless of whether surgical intervention for **venous reflux** is performed.*Monthly intravenous immunoglobulin infusions*- **Intravenous immunoglobulin (IVIG)** is not a standard treatment or prophylactic measure for recurrent cellulitis.- IVIG is typically reserved for **immunodeficiency states** or specific toxin-mediated conditions, rather than common bacterial soft tissue infections.
Practice by Chapter
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free